📊 Score Breakdown
Offering Ability
60
Cash Runway
85
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
45%
📉 Score Deterioration
50%
• Score rose 46 points recently (worsening)
• Score in HIGH risk zone (64/100)
🔄 Reverse Split
45%
• 50-day avg $1.68 approaching $1 threshold
• Only 5 months cash — financial pressure
💰 Capital Raise
35%
• Low cash runway: 5 months remaining
💹 Market Data
Market Cap$279.98M
Shares Outstanding83.08M
Float66.72M
Cash$7.18M
Debt$58.22M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 6.6% shares (2025Q4 vs prior)
24 institutional holders · 4.10M shares
#1
VANGUARD GROUP INC
2.01M shares
#2
BlackRock, Inc.
580.5K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
414.9K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.06M
Days to Cover1.0
% of Float7.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GCTS
📊 GCTS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GCTS Signal Convergence & Dark Pool Activity — StonkWhisper
📄 GCTS Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.